about
The human disease network in terms of dysfunctional regulatory mechanismsInfluence of infliximab on cytokines network and markers of bone remodeling in rheumatoid arthritis patientsEfficacy and safety of dose escalation of infliximab therapy in Japanese patients with psoriasis: Results of the SPREAD study.Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats.Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infliximab in the treatment of rheumatoid arthritis
@en
Infliximab in the treatment of rheumatoid arthritis.
@nl
type
label
Infliximab in the treatment of rheumatoid arthritis
@en
Infliximab in the treatment of rheumatoid arthritis.
@nl
prefLabel
Infliximab in the treatment of rheumatoid arthritis
@en
Infliximab in the treatment of rheumatoid arthritis.
@nl
P2860
P356
P1476
Infliximab in the treatment of rheumatoid arthritis
@en
P2093
A Perdriger
P2860
P304
P356
10.2147/BTT.2009.3099
P577
2009-07-13T00:00:00Z